Recruiting

Apollo Wearable

Sponsor:

The Board of Medicine

Code:

NCT06097442

Conditions

Post-acute Sequelae of SARS-COV-2 Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to examine how Apollo wearable use impacts symptoms and quality of life following long COVID.

Conditions

Post-acute Sequelae of SARS-COV-2 Infection

Study ID

NCT06097442

Start date

Oct 23, 2023

Status verified date

Oct, 2023

Completion date

Mar, 2025

Anticipated

Primary completion date

Dec, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • New purchasers of Apollo who haven't started using their Apollo device or previous users of Apollo who haven't used Apollo in the preceding 14 days.
  • Age 18 years or over
  • Currently experiencing symptoms related to long-COVID according to PASC (self report).
  • Must be experiencing PASC symptoms in at least one of the following domains:

Respiratory-related symptoms Fatigue-related symptoms Neurologic-related symptoms Psychiatric-related symptoms Sleep-related symptoms Change in quality of life/functional status

Exclusion Criteria:

  • Inability to use or access a compatible Android or iOS smartphone
  • Are unable to complete consent and questionnaires written in English
  • Current resident of a European Union (EU) country

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Participants with Long-COVID Using Apollo

Participants with long-COVID symptoms who have consented to be part of this study will use an Apollo device according to a suggested schedule pre-set within their Apollo app, which participants can alter as they see fit.

Primary outcome measure

  • Post-Covid-19 Functional Status Scale (PCFS) [ Time Frame: Monthly for 6 months ]

Central Contacts and Locations

Central contacts

Belinda Tan, MD, PhD

4129450345belinda@theboardofmedicine.org

Ema Perez, BS

18559220057clinical_coordinator@apolloneuro.com

Locations

The Board of Medicine

Recruiting

Pittsburgh, Pennsylvania, United States, 15219

Contacts

Ema Perez, BS

855-922-0057clinical_coordinator@apolloneuro.com

Principal Investigator:

Belinda Tan, MD, PhD

More Information

Sponsor

The Board of Medicine

Last update posted

Oct 27, 2023

Last verified

Oct, 2023

Keywords

  • long-COVID
  • Apollo

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Board of Medicine on 2023-10-27.